ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Coronavirus COVID-19 Update: Hydroxychloroquine and Other Treatments
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="sammmy" data-source="post: 175426" data-attributes="member: 38594"><p>One problem of the French study by Gautret is that out of 26 patients on hydroxychloroquine treatment, 3 were transferred to intensive care units (on days 2,3,4 after starting treatment), and one patient died on day 3. No patients dropped from the control (non treated) group.</p><p></p><p>However, the groups were not statistically equivalent: the treatment group self-selected the hydroxychloroquine treatment because they were significantly older (mean age 51.2 years) than the control group (mean age 37.3 years). Also, 30% of the treatment group had lower track infection (pneumonia) vs only 12.5% in the control group.</p><p></p><p>Hydroxychloroquine is an immune suppressor - it reduced immune inflammation by also reduces the number of lymphocytes (seen it in a HIV study). I wonder if it is best if it is combined with something that increases lymphocytes such as isoprinosine or thymosine alpha-1. I've tried both compounds myself and they do increase lymphocytes significantly.</p></blockquote><p></p>
[QUOTE="sammmy, post: 175426, member: 38594"] One problem of the French study by Gautret is that out of 26 patients on hydroxychloroquine treatment, 3 were transferred to intensive care units (on days 2,3,4 after starting treatment), and one patient died on day 3. No patients dropped from the control (non treated) group. However, the groups were not statistically equivalent: the treatment group self-selected the hydroxychloroquine treatment because they were significantly older (mean age 51.2 years) than the control group (mean age 37.3 years). Also, 30% of the treatment group had lower track infection (pneumonia) vs only 12.5% in the control group. Hydroxychloroquine is an immune suppressor - it reduced immune inflammation by also reduces the number of lymphocytes (seen it in a HIV study). I wonder if it is best if it is combined with something that increases lymphocytes such as isoprinosine or thymosine alpha-1. I've tried both compounds myself and they do increase lymphocytes significantly. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Coronavirus COVID-19 Update: Hydroxychloroquine and Other Treatments
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top